Weigang Shu

467 total citations
10 papers, 366 citations indexed

About

Weigang Shu is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Weigang Shu has authored 10 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Immunology and 2 papers in Oncology. Recurrent topics in Weigang Shu's work include Inflammatory Bowel Disease (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Response and Inflammation (2 papers). Weigang Shu is often cited by papers focused on Inflammatory Bowel Disease (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Response and Inflammation (2 papers). Weigang Shu collaborates with scholars based in China, United States and Canada. Weigang Shu's co-authors include Zhanju Liu, Zhi Pang, Wei Wu, Guangxi Zhou, Leilei Fang, Mingming Sun, Yingzi Cong, Jian Lin, Cui Zhang and Huili Wu and has published in prestigious journals such as Gastroenterology, Carcinogenesis and Inflammatory Bowel Diseases.

In The Last Decade

Weigang Shu

10 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weigang Shu China	8	147	142	103	63	59	10	366
Ritian Lin China	12	164 1.1×	133 0.9×	81 0.8×	43 0.7×	43 0.7×	17	341
Thomas W. Dennison United Kingdom	4	121 0.8×	248 1.7×	79 0.8×	39 0.6×	37 0.6×	4	422
Jingling Su China	10	132 0.9×	256 1.8×	179 1.7×	67 1.1×	78 1.3×	16	509
Gerolamo Bevivino Italy	11	116 0.8×	106 0.7×	143 1.4×	77 1.2×	77 1.3×	19	345
Markus Tschurtschenthaler Germany	10	179 1.2×	127 0.9×	51 0.5×	106 1.7×	98 1.7×	23	419
Elena Ferrer-Picón Spain	3	136 0.9×	64 0.5×	123 1.2×	93 1.5×	28 0.5×	4	296
Karen Dubois‐Camacho Chile	11	180 1.2×	161 1.1×	135 1.3×	105 1.7×	59 1.0×	20	471
Tatsuhiko Hayashi Japan	8	110 0.7×	160 1.1×	99 1.0×	57 0.9×	88 1.5×	26	418
Hidetomo Himuro Japan	8	116 0.8×	150 1.1×	95 0.9×	139 2.2×	24 0.4×	19	390
Felicia M. Bloemendaal Netherlands	7	122 0.8×	140 1.0×	92 0.9×	26 0.4×	53 0.9×	8	314

Countries citing papers authored by Weigang Shu

Since Specialization

Citations

This map shows the geographic impact of Weigang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang Shu more than expected).

Fields of papers citing papers by Weigang Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weigang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang Shu. The network helps show where Weigang Shu may publish in the future.

Co-authorship network of co-authors of Weigang Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Weigang Shu. A scholar is included among the top collaborators of Weigang Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigang Shu. Weigang Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Shu, Weigang, et al.. (2024). Infliximab modifies CD74-mediated lymphatic abnormalities and adipose tissue alterations in creeping fat of Crohn’s disease. Inflammation Research. 73(7). 1157–1172. 2 indexed citations

Shu, Weigang, et al.. (2024). Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation of Crohn's disease. Clinical and Translational Medicine. 14(12). e70086–e70086. 1 indexed citations

Shu, Weigang, Yongheng Wang, Lei Zhang, et al.. (2023). Single-cell Expression Atlas Reveals Cell Heterogeneity in the Creeping Fat of Crohn’s Disease. Inflammatory Bowel Diseases. 29(6). 850–865. 15 indexed citations

Zhang, Lei, et al.. (2022). ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome. Stem Cell Research & Therapy. 13(1). 448–448. 25 indexed citations

Shu, Weigang, Zhi Pang, Jian Lin, et al.. (2019). Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease. Mediators of Inflammation. 2019. 1–13. 19 indexed citations

Zhang, Cui, Weigang Shu, Guangxi Zhou, et al.. (2018). Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease. Mediators of Inflammation. 2018. 1–12. 56 indexed citations

Deng, Jiali, Tianming Yu, Shanghai Chen, et al.. (2018). ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides. Gastroenterology. 156(4). 1098–1111. 90 indexed citations

Lin, Ritian, Weigang Shu, Mingming Sun, et al.. (2018). Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease. Journal of Translational Medicine. 16(1). 359–359. 53 indexed citations

Fang, Leilei, Zhi Pang, Weigang Shu, et al.. (2018). Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn’s Disease. Inflammatory Bowel Diseases. 24(8). 1733–1744. 43 indexed citations

10.

Zhou, Guangxi, Yang Song, Wenjing Yang, et al.. (2017). CD177+ neutrophils suppress epithelial cell tumourigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer. Carcinogenesis. 39(2). 272–282. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact